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INDIVIDUAL POSITIONING: A COMPARATIVE STUDY OFADJUVANT BREAST
RADIOTHERAPY IN THE PRONE VERSUS SUPINE POSITION
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Purpose: To study breast radiotherapy in the prone vs. supine positions through dosimetry and clinical implemen-
tation.
Methods and Materials: Conformal radiotherapy plans in 61 patients requiring only breast irradiation were de-
veloped for both the prone and supine positions. After evaluation of the of the first 20 plan pairs, the patients were
irradiated in the prone or supine position in a randomized fashion. These cases were analyzed for repositioning
accuracy and skin reactions related to treatment position and patient characteristics.
Results: The planning target volume covered with 47.5–53.5 Gy in the prone vs. the supine position was 85.1% ±
4.2% vs. 89.2 ± 2.2%, respectively (p < 0.0001). Radiation exposure of the ipsilateral lung, expressed in terms of the
mean lung dose and the V20Gy, was dramatically lower in the prone vs. supine position (p < 0.0001), but the doses to
the heart did not differ. There was no difference in the need to correct positioning during radiotherapy, but the
extent of displacement was significantly higher in the prone vs. supine position (p = 0.021). The repositioning
accuracy in the prone position exhibited an improvement over time and did not depend on any patient-related
parameters. Significantly more radiodermatitis of Grade 1–2 developed following prone vs. supine irradiation
(p = 0.025).
Conclusions: Conformal breast radiotherapy is feasible in the prone position. Its primary advantage is the substan-
tially lower radiation dose to the ipsilateral lung. The higher dose inhomogeneity and increased rate of Grade 1–2
skin toxicity, however, may be of concern.  2009 Elsevier Inc.
Breast cancer, Conformal radiotherapy, Prone treatment position, Supine treatment position, Repositioning
accuracy.
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Postoperative radiotherapy has become an integral part of the
complex treatment of breast cancer. The risk of late radio-
genic sequelae such as lung fibrosis, cardiovascular events,
or secondary cancers increases with radiation exposure of
the organs at risk (OARs) (1–4), and selective irradiation
of the target organ is therefore mandatory. The simplest
way to protect the OARs during breast radiotherapy is indi-
vidual patient positioning. It has been observed that a prone
position during breast radiotherapy results in a substantially
lower dose to OARs such as the ipsilateral lung (5–9) and the
heart (5, 8), with the additional advantage of improved dose
homogeneity (5, 6, 9). This mode of positioning has been
shown to be feasible (10, 11), even in obese patients (8),
and to provide a similar long-term outcome and toxicity as
with standard supine tangents (11, 12). Because we had
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Go¨teborg, Sweden, September 14–18, 2008.94earlier found the prone position to be helpful in a few diffi-
cult cases, we set out to perform a prospective study to
compare radiotherapy in the prone position with our usual
technique in the supine position with excellent repositioning
accuracy. The study comprised two phases: the first phase
served as a setup period for the acquisition of experience
with patient positioning and radiotherapy planning in the
prone position, but the radiotherapy was in fact delivered
in the conventional supine position; in the second phase, ra-
diotherapy administered in the prone vs. the supine position
in a randomized fashion was studied. The radiotherapy plans
were analyzed for the overall study population, whereas the
implementation of breast radiotherapy in the prone position
was the subject of only the second phase of the study. We
aimed to identify those patients who benefit most from prone
positioning by means of dosimetry (dose homogeneity and
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tioning accuracy).
METHODS AND MATERIALS
The study was approved by the Institutional Review Board of the
University of Szeged, and all enrolled patients gave their written
informed consent before being registered in the study.
Early breast cancer patients after surgery requiring only radiother-
apy of the operated breast were included in the study. No restriction
existed regarding the size of the breast or the patient.
In the first phase of the study (n = 20), although radiotherapy plan-
ning was performed in both positions, all patients received radiother-
apy in the supine position. The 41 patients enrolled in the second
phase were randomized to radiotherapy in the prone vs. the supine
position, but the position for radiotherapy randomized to the patient
was blinded to the physician who performed the contouring.
The patients were positioned on the supine thorax and the prone
breast modules of the AIO (All In One) Solution (ORFIT, Wijne-
gem, Belgium) system, which contains special cushion sets fixed
to a universal baseplate. In the supine position, the patient was
laid on a 15 thorax wedge cushion with both arms elevated, resting
on an arm support, and held on an adjustable grip pole. The head was
placed in the head support secured to a supplementary baseplate at-
tached to the thorax cushion. In the prone position, the head was
resting on a pillow, both arms were placed superolaterally, sup-
ported by the cranial part of the prone breast cushion, and the target
breast lay across the semicircular aperture of the platform. The
patient was rotated slightly to allow the ipsilateral chest wall to ex-
tend into the aperture. A thermoplastic mask (five-point fixation,
breast precut; ORFIT) was applied in the supine position, molded
around the chin, the neck, the thorax (excluding the target breast),
and the abdomen. The opposite breast was covered with the mask
and carefully positioned away from the radiation fields. Mask fixa-
tion was not used in the prone position, but a polyfoam wedge was
placed under the contralateral breast to displace it. On the basis of
experience gained during the first phase of the study, in the second
41 patients, a different polyfoam wedge was applied as a new devel-
opment of the AIO system for better protection of the opposite breast
(Fig. 1). Positioning landmarks were drawn on the skin or the mask,
using two lateral lasers and one overhead laser. All patients were
scanned on a Somatom Emotion 6 CT simulator (Siemens, Erlan-
gen, Germany) in both positions. The planning target volume
(PTV) and OARs were contoured on the CT slices throughout the
entire planning volume in the XiO (CMS, Maryland Heights,
MO) treatment planning system, according to the local protocol
(13). The PTV was defined as the entire breast delineated on the
CT data set, extending to within 4 mm of the skin surface. Treatment
plans were developed by applying conventional 6-MV tangential
photon fields set up isocentrically and a median of 2 (range, 1–3) in-
dividually weighted 6/15-MV segmental fields superimposed on the
tangential fields by using a multileaf collimator. Wedges were used
in almost all cases. A mean dose to the PTV of 50 Gy and a uniform
distribution ( 10%) of the prescribed dose to 95% of the PTV were
aimed for. Dose homogeneity within the PTV was characterized by
the volume of the breast receiving at least 47.5 Gy but less than 53.5
Gy (V95%–107%). Radiation exposure of the OARs (the volume of the
ipsilateral lung receiving more than 20 Gy [V20Gy], the mean lung
dose [MLD], the mean dose to the heart [MHD], the volume of
the heart receiving more than 25 or 30 Gy [V25Gy and V30Gy], the
volume of the contralateral breast receiving more than 5 Gy
[V5Gy], and the mean dose to the contralateral breast) was registeredin both positions. The central lung distance (CLD) and breast
separation were determined in the supine position as measures of
the patient anatomy.
The objectives in the second phase of the study were patient ad-
herence to the protocol, repositioning accuracy, and toxicity during
radiotherapy. Before the commencement of radiotherapy, the
position of the isocenter in the patient was checked under the CT
simulator. The necessary displacement in three dimensions was reg-
istered as the first datum of the repositioning accuracy. Radiotherapy
was delivered with a linear accelerator (Primus, Siemens) in five
fractions per week. The accuracy of patient repositioning during ra-
diotherapy was checked three times per week with an electronic por-
tal imaging device (Beamview version 2.2, Siemens), with the help
of radio-opaque markers placed on the skin and mask as reference
markers. (The dose delivered by portal imaging was taken into con-
sideration in the calculation of the final dose received by the patient.)
One portal image for one of the tangentional beams was recorded
and compared with the corresponding beam’s eye view digitally re-
constructed radiograph generated from the planning system. The
need to correct the position of the table in two dimensions was estab-
lished and recorded by one or two physicians (AN or ZK). Analysis
of each port image involved determination of the distances between
the radio-opaque skin markers, and measurements of the CLD, the
lung area included in the field, the central flash distance, and the in-
ferior central margin (14, 15). The action level was set at 3 mm. Sys-
tematic and random errors generated from the three-dimensional
Fig. 1. Typical supine and prone positioning during breast radio-
therapy.
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sional vector of displacement during the radiotherapy were calcu-
lated according to conventional definitions (16, 17). Acute skin
reactions (graded by the Common Terminology Criteria for Adverse
Events, version 3.0) were compared in 41 patients randomized to ra-
diotherapy in the prone vs. supine position, at the end of the whole
breast irradiation. The relations between the data obtained by anal-
ysis of the radiotherapy plans and repositioning accuracy vs. the
patient characteristics were analyzed with the Student t test, the
chi-square test, regression analysis, analysis of variance, and logistic
regression. Statistical analysis was performed with SPSS 11.0 for
Windows.
RESULTS
The first phase of the study and the second feasibility phase
involved 20 and 41 patients, respectively. The mean ( SD)
age of the overall study population was 56.0  9.6 (range,
29.3–73.9), and that of the second phase was 56.6  9.9
(range, 29.3–73.6) years. Twenty-seven patients underwent
right-sided and 34 left-sided breast irradiation. The age,
weight, waist, hip size, and breast separation did not differ
significantly between patients randomized to radiotherapy
in the prone or the supine position (Table 1). Tumor bed
boost irradiation and systemic treatments did not differ
significantly between the two groups.
Radiotherapy plans for the prone vs. the supine position
The radiotherapy plans were first analyzed in the overall
population. Mean ( SD) percentage PTV covered by
47.5–53.5 Gy (V95%–107%) in the prone vs. the supine position
was 85.1 4.2% and 89.2 2.2%, respectively (p < 0.0001).
Dose homogeneity did not depend on PTV or breast separa-
tion. The irradiated volume of and the dose to the ipsilateral
lung, determined in terms of MLD and V20Gy, were dramati-
cally lower in the prone position than in the supine position
(Table 2). No significant difference was detected in the
mean dose to the heart and the volumes of the heart receiving
at least 25 Gy or 30 Gy in 34 left-sided breast cancer patients
according to their position during radiotherapy (Table 2). The
first 20 pairs of treatment plans revealed significantly higher
doses to the contralateral breast in the prone position than in
the supine position. In the second phase of the study (n = 41),
as a consequence of the more complete displacement of the
opposite breast due to the use of a new polyfoam wedge, there
was no longer any significant difference (Table 3).
We hoped to identify parameters related to patient anat-
omy that indicate high lung doses if radiotherapy is given
in the supine position to select those patients who would ben-
efit most from radiotherapy in the prone position. With regard
to the volume of the target breast, breast separation, and
CLD, only CLD was significantly associated with MLD
(r = 0.843, p < 0.0001) and V20Gy (r = 0.733, p < 0.0001).
Implementation of breast radiotherapy in the prone
position
In the second phase of the study, adherence to the study
protocol, repositioning accuracy, and early skin reactionsT
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Breast radiotherapy in the prone position d Z. VARGA et al. 97Table 2. Radiation doses to the ipsilateral lung and the heart in the overall study population (mean  SD)
Lung (n = 61) Heart (n = 34)
MLD (Gy) V20Gy (%) Mean dose (Gy) V25Gy (%) V30Gy (%)
Supine 7.45  2.62 14.3  5.4 3.51  2.33 4.7  4.6 4.1  4.3
Prone 2.02  1.23 3.3  2.5 3.18  1.31 3.6  2.5 3.0  2.2
p value <0.0001 <0.0001 0.413 0.171 0.152
Abbreviation: MLD = mean lung dose.were analyzed. The protocol was tolerated well by all
patients; only one treated in the prone position required
a 1-week break because of radiodermatitis. It was necessary
to correct the location of the isocenter in the simulator or
the position of the table during radiotherapy in 20.3% (61/
301) and 20.3% (62/306) of all checks in the prone and the
supine position, respectively (p = 0.999). The mean length
of the displacement vector was 8.06  4.66 mm (range,
3.00–22.56 mm) and 6.60  3.05 mm (range, 3.00–21.19
mm) in the prone and supine positions, respectively (p =
0.021). The population random errors were 3.89 mm and
2.97 mm, whereas the population systematic errors were
0.86 mm and 0.82 mm for the prone and the supine position,
respectively. The random errors in the two groups are shown
in Table 4. A trend was detected for better overall reposition-
ing accuracy in the supine position (p = 0.061). We analyzed
whether repositioning accuracy changed from patient to pa-
tient during the study period. The individual random errors
for repositioning in the prone position decreased with time,
whereas no change was detected in the group randomized
to radiotherapy in the supine position (Fig. 2). Repositioning
accuracy in the prone position did not depend on any patient-
related parameter. In the supine position, however, it was sig-
nificantly related to lower weight (p = 0.01), body mass index
(p = 0.011), waist size (p = 0.039), volume of the ipsilateral
breast (p = 0.007), and breast separation (p = 0.001). Grade 1
radiodermatitis developed in 55% and 38.1% of patients and
Grade 2 radiodermatitis in 35% and 19.5% of the patients re-
ceiving radiotherapy in the prone or the supine position,
respectively (p = 0.025). Acute skin reactions were not re-
lated to dose homogeneity in the PTV or the random errors
for repositioning, regarded as measures of systematic and
random overdosage, respectively.
DISCUSSION
We evaluated our initial experience regarding the dosime-
try and feasibility of conformal breast radiotherapy in theprone position and identified its place in everyday practice.
Our results indicate that its primary advantage is the signifi-
cantly reduced radiation exposure of the ipsilateral lung. The
doses to the heart and the contralateral breast are similar in
the prone and supine positions. Special practice in and atten-
tion to accurate repositioning are necessary if the prone posi-
tion is applied, and dose inhomogeneity and acute skin
reactions may increase slightly.
There have been few studies on prone breast radiotherapy.
Some focused on dose distribution (6, 7, 9, 18) and others on
clinical implementation (11, 12, 14, 19, 20); only one study
with both dosimetric aspects and feasibility (10). This study
is the first randomized clinical trial to compare breast radio-
therapy in the prone vs. the supine position.
Use of the prone position during breast radiotherapy raises
special considerations because of the altered shape, motion,
and position of the organs present in the region. The altered
shape of the target breast hanging down across the aperture
of the positioning device results in a different dose distribu-
tion relative to that in the supine position. Improved dose uni-
formity, particularly avoidance of an overdosage within the
PTV, have been associated with a better cosmetic outcome
(21, 22). A higher dose inhomogeneity is related to larger
breasts if conventional tangent beams are used (21). Buijsen
et al. (9) compared prone and supine breast irradiation in 10
patients with pendulous breasts, and concluded that the dose
homogeneity was better in the prone than the supine position.
In fact, this was based on a comparison of the PTV overdosed
(V105% and V107%) in the supine vs. prone position, but the
significantly lower mean dose and PTV coverage represent-
ing an underdosage were neglected. Similarly, in another
study (6), larger volumes receiving > 52.5 Gy within the
PTV were found in the supine than the prone position, but
no other information on dose distribution was reported. We
examined V95%–107% as a measure of dose homogeneity
within the PTV, according to International Commission on
Radiation Units and Measurements Report 62 (23), and
found that the dose distribution was significantly moreTable 3. Radiation dose to the opposite breast in the two consecutive cohorts of the study
First phase (n = 20) Second phase (n = 41) p for first vs. second phase
Mean dose (Gy) V5Gy (%) Mean dose (Gy) V5Gy (%) Mean dose V5Gy
Supine 0.85  0.47 2.7  2.0 0.61  0.73 1.7  2.8 0.096 0.073
Prone 1.26  0.78 4.5  3.4 0.74  0.44 2.2  2.0 0.00092 0.001
p for supine vs. prone 0.0038 0.0057 0.162 0.159
98 I. J. Radiation Oncology d Biology d Physics Volume 75, Number 1, 2009uniform in the supine position, regardless of the size or shape
of the target breast. None of the radiotherapy plans indicated
measurable volumes receiving > 53.5 Gy. Our dose prescrip-
tion strategy was different from those of Buijsen et al. (9),
and Griem et al. (6). A mean dose of 50 Gy was prescribed
to the entire PTV, provided that the dose range is between
45 and 55 Gy in at least 95% of the PTV, instead of specify-
ing a dose to a dose prescription point. We believe that our
approach reliably represents the dose homogeneity within
the PTV. Goodman et al. (18) reported a simplified inten-
sity-modulated radiation therapy (IMRT) technique that im-
proved dose homogeneity within the target breast in the
prone position compared with the unacceptably high doses
generated if conventional tangents were used. The greatest
improvement was seen in women with the most pendulous
breasts. Although in our study dose uniformity was accept-
able in both positions, in certain cases, the IMRT approach
could be followed to prevent the early and late consequences
of dose inhomogeneity. In accordance with these data, in an
Table 4. Random errors for repositioning in the prone and
supine positions
Mean  SE (mm) Median (mm)
Supine 2.75  0.27 2.58
Prone 3.46  0.37 3.48
p value 0.061
Fig. 2. Random errors for repositioning among the patients who
received radiotherapy prone (a) and those received radiotherapy
supine (b) by sequence of enrolment in the study.investigation of 35 patients with large pendulous breasts,
Mahe et al. (10) found that when conventional tangents
were used, the dose was 105%–110% in one third of patients.
Despite the use of in-field segments, we observed hot spots at
the top and bottom of the target breast in the prone position,
which is consistent with the experience of Mahe et al. The ap-
plication of intensity-modulated beams in our study may
have played a role in the apparent lack of a relation between
dose uniformity and breast size.
Because of the different shape of the chest wall when the
patient is positioned prone, the lung volume included in the
tangent fields is considerably less. All authors agree that
lung doses are dramatically reduced if breast radiotherapy
is performed with the patient prone (5–9). The beneficial ef-
fect of prone positioning on the protection of the ipsilateral
lung is further enhanced if the almost absent intrafractional
motion of the chest wall is taken into account for the calcula-
tion of safety margins around the CTV (20, 24, 25).
When left-sided irradiation is performed, the irradiated
volume of the heart is not reduced, despite the fact that less
intrathoracic volume is exposed to radiation in the prone
than in the supine position. Reports on heart doses are not
concordant, however. Some studies suggest a reduction in
heart doses as a result of prone positioning but do not provide
direct comparisons with supine positioning (5, 8). Others are
consistent with our results in showing no significant differ-
ence in doses to the heart as a function of the treatment posi-
tion (6, 7, 9). This finding may be accepted if the change in
position of the heart by treatment position is taken into con-
sideration. In fact, the prone position causes an anterior dis-
placement of the heart within the thorax by 19 mm on
average, as demonstrated by CT and MRI measurements in
breast cancer patients receiving radiotherapy (26).
Because breast radiotherapy increases the risk of late con-
tralateral breast cancer by 18%–34%, special attention is nec-
essary to protect the opposite breast (3, 4). Although some
studies allude to the radiation dose to the opposite breast in
the prone position, detailed dose–volume histogram data
have not been provided (5, 6). No widely accepted dose con-
straints exist for the contralateral breast. We registered V5Gy
and the mean dose to the healthy breast. In the first phase of
the study, we detected higher doses to the opposite breast in
the prone than supine position, a consequence of suboptimal
positioning in the prone state. Following revision of the
positioning method, no difference was observed in the sec-
ond phase of the study. We consider careful application of
the polyfoam wedge in the prone position, and of mask fixa-
tion in the supine position, to be important in removing the
opposite breast from the radiation fields.
The largest prospective Phase I–II study on prone breast ir-
radiation is that of Formenti et al. (8). Accelerated whole
breast radiotherapy was feasible in 90 patients, with high
setup reproducibility, although numerical data were not pro-
vided. In another feasibility study (10), prolonged adequate
immobilization could not be achieved in 3 of 35 patients
with large pendulous breasts in the prone position. In one ret-
rospective study (11), 5% of the patients during prone breast
Breast radiotherapy in the prone position d Z. VARGA et al. 99radiotherapy complained of chest wall or rib pain, and 2 of
248 patients suffered a rib fracture (11), as did 1 of 35 in
the previous study (10). All our patients considered the prone
radiotherapy convenient and completed the course of radio-
therapy. We believe that the comfortable positioning system
was essential to achieve such good adherence to the protocol.
It is our view that repositioning accuracy is a key condition
for radiotherapy, particularly if inverse or forward intensity
modulation is applied (24, 25). During simulation in 308
patients with various cancer sites, Schu¨ller et al. (27) found
that the repositioning accuracy was improved in the entire
patient population if positioning aids or mask fixation were
used, but this was not affected by prone or supine positioning.
Breast irradiation was performed without mask fixation in the
supine position for 64 patients. Of the various tumor sites, the
breast exhibited the poorest repositioning accuracy. Dis-
placement was carried out in 27 patients (42.2%) and ex-
ceeded 1 cm in many cases. In another study of 25 breast
cancer patients irradiated in the supine position (28), the iso-
center displacement on simulation was 5.7 mm on average.
Morrow et al. (20) studied interfractional error in reposition-
ing in 15 patients and recommended image guidance during
prone breast radiotherapy because of the need for frequent
and large displacements. In agreement with our results,
they observed no relation between the breast size and the re-
positioning accuracy. Interestingly, however, we found that
the repositioning accuracy in the supine position is signifi-
cantly worse in obese patients. To the best of our knowledge,
no such data have been published previously. If confirmed,
they indicate that increased attention must be paid to the po-
sition of overweight patients during breast radiotherapy. We
believe that the relatively good repositioning accuracy in our
study, was related to the comfortable positioning device usedfor both the prone and the supine position and to the mask fix-
ation used in the supine position. Repositioning accuracy in
the prone position improved over time, indicating the need
for experience and expertise. Furthermore, our study war-
rants the development of mask fixation in the prone position,
which would reduce setup uncertainty.
In other publications (10, 11), acute skin reactions after
breast radiotherapy in the prone position were reported in
similar incidences as among our patients. Mahe et al. (10)
found that acute skin reactions were most frequent at the
top and the bottom of the fields, in accordance with the
high dose regions. In our study, radiodermatitis in the prone
position was not related to the size of the breast or the dose
inhomogeneity in it.
Merchant and McCormick (5) recommend breast radio-
therapy in the prone position if the supine position is likely
to result in unacceptable dose inhomogeneity or significant
doses to normal tissues. We hoped to identify those patients
who would benefit most from the prone position during
breast radiotherapy. Because we could not detect any advan-
tage of prone radiotherapy other than the absence of radiation
exposure of the lung, we set out to identify those patient-re-
lated parameters that are associated with a higher lung dose if
the patient is irradiated in a supine position. Consideration of
breast volume, breast separation, and CLD as measures of the
PTV shape indicated that only CLD was related to the dose to
the ipsilateral lung. Thus, we recommend monitoring of the
CLD as a primary measure for the indication of prone radio-
therapy. Moreover, because the risk of early and late lung se-
quelae is strongly related to patient age (13), the presence of
lung disease, and possibly to certain systemic therapies, these
factors should be taken into account when a decision is made
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